Pharmacologic management of post-tonsillectomy pain in children

Daniel R Jensen1,2

  • 1Division of Otolaryngology, Children's Mercy Hospital, Kansas City, MO, USA.

Insights

Managing severe pain after pediatric tonsillectomy is challenging. This review offers strategies for effective pain control using medication combinations and patient-specific factors to minimize harm.

Area of Science:

  • Pediatric Surgery
  • Pain Management
  • Anesthesiology

Background:

  • Tonsillectomy is a common pediatric outpatient procedure.
  • Severe and prolonged postoperative pain is a frequent complication.
  • Caregiver undertreatment and lack of clear instructions hinder adequate pain management.

Purpose of the Study:

  • To review the current literature on pediatric tonsillectomy pain management.
  • To present an approach for maximizing pain control while minimizing harm.
  • To address the challenges of medication safety and efficacy.

Main Methods:

  • Literature review of current research on tonsillectomy pain.
  • Analysis of medication safety and efficacy data.
  • Development of a patient-specific management strategy.

Main Results:

  • Adequate pain control post-tonsillectomy remains a significant challenge.
  • Existing analgesic options have variable efficacy and safety profiles.
  • Conflicting research results contribute to practice pattern variance.

Conclusions:

  • A comprehensive approach combining medications and patient-specific factors is needed.
  • Enhanced caregiver education and clear instructions are crucial.
  • Further research is necessary to optimize pain management strategies.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
215
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
6.7K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
751
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
971
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
177
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
540